Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Creative BioStructure

Creative BioStructure is specialized in providing contract Structural Biology services to both academia and biotechnology/pharmaceutical industry. Featuring one of the most experienced teams in the field of Structural Biology, Creative BioStructure offers a full range of structural services, from molecular cloning to three-dimensional protein structure determination using X-ray Crystallography and NMR technology. Our expertise permits us to offer first class services in the most cost-effective manner.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications Logo

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Sales, Training

- PMLiVE

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Sales

Company Details

Creative BioStructure
1-516-855-7709
Contact Creative BioStructure
Website

 Latest Content from PMHub 

Alzheimer’s disease: reviewing the immediate treatment horizon

White Papers and Resources | September 1, 2016 | Blue Latitude Health

Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.

A stumble, but not a fall – what’s next for Opdivo?

White Papers and Resources | August 25, 2016 | Blue Latitude Health

Blue Latitude Health's Louis Perdios talks about the daunting challenges faced by BMS after Opdivo's disappointing results.

Meet Anthill at conferences in London

White Papers and Resources | August 19, 2016 | Anthill Agency

October, the month of multichannel pharma marketing in London. Meet us at DigiPharm and Multichannel Excellence Summit

Immuno-oncology; bringing patients closer to treatment

White Papers and Resources | August 18, 2016 | Blue Latitude Health

What do the new immunotherapies in oncology mean for those stakeholders who need to understand and make decisions about treatment?

Therapy Watch market snapshots

White Papers and Resources | August 12, 2016 | Inizio

Therapy Watch is a ‘real-time’ syndicated market tracking tool that provides marketing teams, brand managers and market researchers with strategic and tactical market information. Run entirely online to ensure speed,...

Case Study: Private market opportunity for a travel vaccine

White Papers and Resources | August 12, 2016 | Inizio

Our client needed exploratory research to determine the global opportunity for a new travel vaccine in the private market. It was crucial to determine:Which markets had the highest potential to...

Infographic: Conference Live

White Papers and Resources | August 12, 2016 | Inizio

Conference Live gives you real-time insights, utilising the multimedia functionality of the smartphone in an innovative mobile app methodology. We conduct mobile conference research amongst physicians attending conferences, giving our clients...

Blog: The Cost of Counterfeits

White Papers and Resources | August 12, 2016 | Inizio

The sale of counterfeit drugs is growing at twice the rate of legitimate pharmaceuticals and pharma companies stand to lose more than just profits from the fallout of counterfeit identification.

Video: Self-pay and Emerging Markets

White Papers and Resources | August 12, 2016 | Inizio

A key feature of emerging markets is that patients often have to pay for a high proportion of their healthcare costs themselves. For all but the most severe conditions, public...

News: Therapy Watch HCV expands into 4 additional EU markets

White Papers and Resources | August 12, 2016 | Inizio

The HCV market has been growing and changing remarkably quickly and with the development of new and improving drugs, the treatment of HCV has moved on in a short space...